Yhdistys edistää solubiologian tutkimusta, koulutusta, tiedotusta ja työpaikkojen perustamista solubiologeille harjoittaen koulutus- ja tiedotustoimintaa.
ChemBio Finland 2026 – kemian- ja bioalan ammattitapahtuma valtaa Helsingin Messukeskuksen 15.-16.4.2026. Suomen Solubiologit osallistuu tapahtumaan ensimmäistä kertaa järjestämällä keskiviikkona 15.4. klo 10.30-15.30 salissa 3 symposiumin otsikolla “Beyond the Animal Model: Ethical, Technological and Human-Based Innovations in Biomedical Research”.
Symposiumissa ovat puhumassa Miina Björninen (Tampereen yliopisto), Cecilia Sahlgren (Åbo Akademi), Mikko Airavaara (Helsingin yliopisto), Aarno Palotie (FIMM, Helsingin yliopisto), Miika Fadjukov (Vaste Co), Ilona Mäkinen (Tampereen yliopisto), Joel Janhonen (Turun yliopisto, Bioetiikan instituutti), Dario Greco (Tampereen yliopisto) ja Jiri Funda (Euro-BioImaging).
Erinomaisen puhujakattauksen lisäksi symposiumin yhteistyökumppaneinamme ovat Euro-BioImaging, Scellex, Bioname ja Vaste Co.
Jäsenemme voivat seurata symposiumin ohjelmaa myös etäyhteydellä. Symposiumin online-rekisteröityminen on avoinna vain jäsenillemme tämän linkin kautta: https://forms.gle/Wrp41MeQNGfap4UB8
ChemBio-messuille on ilmainen sisäänpääsy, mutta rekisteröityminen vaaditaan. Tarkempia lisätietoja symposiumin ohjelmasta, messuille rekisteröitymisestä ja muusta messuihin liittyvästä ChemBion verkkosivuilta.
***
ChemBio Finland 2026 – the professional event for the chemistry and biosciences fields – will take over the Helsinki Expo and Convention Centre on April 15–16, 2026. The Finnish Society for Cell Biology will participate in the event for the first time by organizing a symposium on Wednesday, April 15, from 10:30 to 15:30 in room 3. The title of the symposium is ”Beyond the Animal Model: Ethical, Technological and Human-Based Innovations in Biomedical Research”.
The symposium will feature talks by Miina Björninen (Tampere University), Cecilia Sahlgren (Åbo Akademi University), Mikko Airavaara (University of Helsinki), Aarno Palotie (FIMM, University of Helsinki), Miika Fadjukov (Vaste Co), Ilona Mäkinen(Tampere University), Joel Janhonen (University of Turku, Institute of Bioethics), Dario Greco (Tampere University), and Jiri Funda (Euro-BioImaging).
In addition to our excellent lineup of speakers, our symposium partners include Euro‑BioImaging, Scellex, Bioname, and Vaste Co.
Members of SSB may also follow the symposium program remotely. Online registration for the symposium is open exclusively to our members via this link: https://forms.gle/Wrp41MeQNGfap4UB8
Entry to the ChemBio expo is free of charge, but registration is required. More detailed information about the symposium program, registration, and other ChemBio-related matters can be found on the ChemBio Website.
University of Helsinki is seeking a Project Planner to support an international biomedical research team at the Meilahti Campus. The position starts in June 2026 (or as agreed) and is initially funded for 12 months, with the possibility of extension.
The Project Planner will work closely with the Principal Investigator to support grant applications, research administration, project coordination, and laboratory management. Key responsibilities include coordinating grant proposals and reporting, organizing project meetings, monitoring milestones and deliverables, supporting ethics applications and regulatory compliance, coordinating collaborations with clinicians, biobanks, and core facilities, and assisting with scientific publication processes. The role also contributes to improving laboratory operations, documentation systems, onboarding practices, and research reproducibility.
Applicants must hold a PhD in Systems Biology, Immunology, Metabolism, RNA Biology, or a related field. Experience in research project administration, grant preparation, or research support roles is required. Strong scientific writing, communication, organizational, and networking skills are essential, along with excellent English proficiency.
The salary is approximately €3,900/month, and the position offers an opportunity to contribute to internationally collaborative biomedical research projects.
University of Turku is seeking a Doctoral Researcher to join Professor Jukka Westermarck’s laboratory at the Turku Bioscience Centre. The PhD project focuses on the role of the PP2A inhibitor protein CIP2A and its splice variant NOCIVA in cancer biology, particularly in triple-negative breast cancer (TNBC).
The research aims to uncover how NOCIVA splicing is regulated in cancer and evaluate its potential as a biomarker and therapeutic target. The project combines molecular cancer biology, functional studies, and clinically relevant translational research in a highly international environment with strong cancer research infrastructure.
Applicants must hold an MSc degree and have documented experience in experimental cancer research using cell-based models. Preferred expertise includes CRISPR/Cas9 gene editing, viral gene transfer, bioinformatics, and gene regulation mechanisms. Strong communication and teamwork skills are essential.
The position starts in August 2026, with funding secured until April 2030. Salary is approximately €2500–2600/month initially, according to the Finnish university salary system.
The University of Oulu is a multidisciplinary, international research university, with about 4000 employees who produce new knowledge based on high-standards research and provide research based education to build a more sustainable, smarter, and more humane world. The University of Oulu community has about 17,000 people in total. Our northern scientific community operates globally and creates conditions for the emergence of innovations.
We are now looking for a Postdoctoral Researcher
to join us in the Research Unit for Population Health, a multidisciplinary research unit at the Faculty of Medicine. The postdoctoral position is set within Health Dimensions Theme 1, Multidimensional Mapping of Disease. Health Dimensions is a multidisciplinary research initiative funded by the Research Council of Finland. The research programme brings together researchers an groups exploring the complex, multidimensional nature of human health, with the aim to prevent chronic diseases and multimorbidity through a new level of understanding and acting on these dimensions – lifelong molecular, physiological, environmental, behavioural and societal mechanisms.
About the job
The postdoctoral researcher will join a multidisciplinary research group with expertise in genetic epidemiology, biostatistics, gerontology, clinical medicine, and life‑course health research. Our team investigates the biological (genetics and other omics) determinants of aging, with a particular focus on healthspan, frailty, and age‑related multimorbidity.
In this position, you will work with large-scale genomic, biomarker, and nationwide register data from Finland and other Nordic countries to uncover genetic and molecular mechanisms that shape aging trajectories. The project aims to analyze omics data (e.g., genomics, epigenomics, metabolomics, and proteomics) with Mendelian randomization and machine learning methods with longitudinal health and healthcare information to identify pathways influencing vulnerability, resilience, and health decline across the life course.
Key focus areas
Investigating genetic and molecular determinants of frailty, healthspan, and age‑related diseases
Applying advanced statistical, bioinformatic, and machine learning methods to multi‑omics and population‑level data
Characterizing biological pathways and risk profiles that contribute to heterogeneity in aging and vulnerability
Key duties and responsibilities
Conducting advanced statistical and computational analyses in large and complex datasets
Leading and contributing to scientific manuscripts for peer‑reviewed journals
Presenting research findings at scientific meetings and conferences
Collaborating closely with research group members and external partners in data analysis, interpretation, and dissemination
Contributing to the preparation of research funding applications
What we offer
The support of an experienced and enthusiastic team, with whom you can share your expertise and grow as an expert.
Development and career options of the big organization.
We have an HR Excellence in Research -quality label, which is a recognition awarded by the European Commission for the development of researchers’ working conditions and careers.
Finland is one of the most livable countries in the world, with a high quality of life, safety, an excellent education system, and a competitive economy. Read more about living in Oulu.
Who are you?
We welcome applications from highly motivated candidates with a proven track record of independent research and a strong interest in genetic epidemiology, omics research, and/or bioinformatics as well as a keen interest into health in aging/biological aging.
We expect you to demonstrate the following:
A doctoral degree in a suitable field (e.g. genetic epidemiology, bioinformatics, statistics, data science, or other quantitative field)
A strong interest in the biological determinants of health in aging/biological aging
Solid analytical skills using statistical or programming software (e.g. R, Stata and/or Python)
Excellent communication skills in written and spoken English
A track record of scientific publications
Experience of presenting your work to colleagues and stakeholders
Ability to take initiative, organise your work and complete tasks to an agreed timetable
Ability to work in a multidisciplinary team, with senior and junior colleagues
We also appreciate:
Excellent written and spoken Finnish
Experience in causal inference (e.g. Mendelian randomization) and machine learning methods
Experience of, or interest in, teaching and/or supervision in a higher education setting
Salary
The position is fixed-term for 1 year as of 01.09.2026 or as agreed.
The salary will be based on the levels 5-6 of the demand level chart for teaching and research staff of Finnish universities. In addition, a salary component based on personal work performance will be paid (a maximum of 50 % of the job-specific component). The starting gross salary will be approx. 3700-4200 € per month (before taxes).
A trial period of 6 months is applied to the position.
How to apply?
Interested? If yes, please apply by 15.05.2026 (23:59 Finnish local time) through our recruitment system.
The application should be written in English and include the following:
